期刊文献+

改良ATB Fungus 3法检测糠秕马拉色菌对抗真菌药物的敏感性 被引量:1

Antifungal susceptibility of Malassezia furfur in vitro tested by using modified ATB Fungus 3 method
下载PDF
导出
摘要 目的用改良ATB Fungus 3法测定糠秕马拉色菌的药物敏感性,以了解临床患者呼吸道分离的糠秕马拉色菌对常用抗真菌药物的最低抑菌浓度(MIC)。方法在ATB F2半固体培养基中添加0.5%吐温40和0.5%吐温60,用ATB Fungus 3药敏板条对47株临床分离的糠秕马拉色菌进行MIC检测。结果氟康唑MIC50为>128μg/mL,MICRange为≤1.0~>128μg/mL;5-氟胞嘧啶MIC50为>16μg/mL,MICRange为>16μg/mL;沃尔康唑MIC50为8.0μg/mL,MICRange为≤0.06~>8.0μg/mL;两性霉素B MIC50为4.0μg/mL,MICRange为≤0.5~16μg/mL;伊曲康唑MIC50为1.0μg/mL,MICRange为≤0.125~4.0μg/mL。呼吸道分离的糠秕马拉色菌对5种抗真菌药物的MIC值高于健康人皮肤分离的糠秕马拉色菌及标准菌株ATCC14521。结论改良ATB Fungus 3法操作简便,结果重复性好且易观察。糠秕马拉色菌MIC值的升高可能与患者使用抗真菌药物有关。 Objective To determine the drug-susceptibility of Malassezia furfur by using modified ATB Fungus 3 method and evaluate the minimum inhibitory concentration (MIC) of clinical isolates of Malassezia furfur to antifungal agents. Methods Tween-40 and Tween-60 were added into ATB F2 semisolid culture media with final concentration of 0.5%. The MICs of 5 antifungal agents against 47 strains of Malassezia furfur were determined by ATB Fungus 3 method. Results The MIC50 of fluconazole, 5-flucytosine, voriconazole, amphotericin B and itraconazole against 47 Malassezia furfur strains were more than 128, more than 16, 8. 0, 4.0 and 1.0 μg/mL respectively, and the ranges of MIC were less than or equal tol. 0 to more than 128 μg/mL, more than 16 i.μg/mL, less than or equal to 0.06 to more than 8.0 μg/mL, less than or equal to 0.5 to 16 μg/mL, less than or equal to 0. 125 to 4.0 μg/mL. The results showed that the MIC values of 5 antifungal agents against clinical isolates of Malasseziafurfur from respiratory tract were ~igher than those of typical strain ATCC 14521 and the Malasseziafuffur strains isolated from normal human skin. Conclusion The improved ATB Fungus 3 method with good reproducible results should be easily available for the determination of drug-susceptibility of Malassezia fuffur. The high MICs of antifungal agents against clinical isolates of Malasseziafugrur may be due to increased application of antifungal agents.
作者 陈东科
出处 《临床检验杂志》 CAS CSCD 北大核心 2012年第7期497-499,共3页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(30872719)
关键词 糠秕马拉色菌 ATB FUNGUS 3法 抗真菌药物 最低抑菌浓度 Malassezia furfur ATB Fungus 3 antifungal agent minimum inhibitory concentration
  • 相关文献

参考文献13

二级参考文献23

  • 1李小红,王锰,王瑞,于建斌.115例青年耵聍中马拉色菌存在状态调查[J].中国皮肤性病学杂志,2004,18(10):593-595. 被引量:2
  • 2沈冬,王爱平,李若瑜,万喆.花斑癣患者27株临床分离菌的菌种鉴定[J].中国麻风皮肤病杂志,2005,21(7):578-579. 被引量:1
  • 3崔凡,陶诗沁,沈永年,吕桂霞,陈伟,李筱芳,胡素泉,杨丽佳,刘维达.马拉色菌临床株分类鉴定的研究[J].中华皮肤科杂志,2005,38(8):492-494. 被引量:11
  • 4陈征,冉玉平,熊琳,代亚林,周光平.马拉色菌在新生儿皮肤定植的研究[J].中华皮肤科杂志,2006,39(7):371-373. 被引量:12
  • 5National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2rid ed. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa. 2002.
  • 6Torres-Rodriguez JM, Alvarado-Ramirez E. In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre Yeast One and standard CLSI (NCCLS) M27-A2 methods. J Antimicrob Chemother, 2007, 60: 658-661.
  • 7Eraso E, Ruesga M, Villar-Vidal M, et al. Comparative evaluation of ATB Fungus 2 and Sensititre Yeast One panels for testing in vitro Candida antifungal susceptibility. Rev Iberoam Micol, 2008, 25: 3-6.
  • 8Midgley G.The lipophilic yeasts:state of the art and prespect[J].Medieal Mycology,2000,38(Suppl 1):9-16.
  • 9Takashi S,Masako T,Takako S,et al..New Yeast Species,Malassezia dermatis,Isolated from Patients with Atopic Dermatitis[J].Journal of Clinical Microbiology,2002,40(4):1363-1367.
  • 10Takashi S,Masako T,Minako K,et al..Description of a New Yeast Species,Malassczia japonica,and Its Detection in Patients with Atopic Dermatitis and Healthy Subjects[J].Journal Of Clinical Microbiology,2003,41(10):4695-4699.

共引文献44

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部